Fig. 1.
Commonly targeted and newly emerging immune checkpoints in bladder cancer. Note: CTLA-4, PD-1, TIM-3, TIGIT, and LAG-3 are inhibitory receptors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.